IMC — Reports 2Q/1H24 financial results
WSE-listed Ukrainian agricultural producer IMC reported 1H24 sales of $108m (+51% y-o-y), a gain from change in fair value of biological assets (IAS 41) of $28m (+19%), EBITDA of $38m (+121%; incl. IFRS 16), and net income of $22m (+3.4x). Based on these figures, IMC booked 2Q24 sales of $49m (+64% y-o-y), an IAS 41 gain of $27m (+25%), EBITDA of $33m (+112%), and net income of $25m (+144%), for EBITDA and net margins of 67.7% (+15.4pp y-o-y) and 51.6% (+16.9pp).